0.38% -2.6699

Idexx Laboratories Inc (IDXX)

概要ニュース株価時系列オプションチェーン Financials なぜIDXXが下落しているのか？ディスカッション予測株式分割

なぜIdexx Laboratories Inc（IDXX）の株価が下がっていますか？

2026-03-05 の取引セッション中に、Idexx Laboratories Inc (IDXX) 株の 5.01% 下落を確認しました。これは通常のボラティリティやさまざまな内部および外部要因に起因する可能性がありますが、当社では状況を積極的に監視しており、できるだけ早くタイムリーな最新情報を提供することに注意してください。

2023-11-01:

Idexx Laboratories, Inc. Stock (IDXX) dropped by 1.03% from $399.47 to $395.35 in the trading on Wednesday November 01, 2023. The reasons why IDXX stock down today include:

Q3 financial results: Idexx posted Q3 earnings per share of $2.53, which beat estimates by 16 cents. Revenue increased nearly 9% Y/Y to $916 million, but misses expectations by $11.31 million. It is due to a relative slow down in wellness visits in the quarter, which may reflect some macro impacts on demand at the clinic level.
Full year revenue guidance: Idexx revised its full year revenue guidance to $3.635 - $3.65 billion from a previous forecast of $3.66 - $3.715 billion. The consensus revenue estimate is $3.68 billion. The organic growth guidance assumes a level of continued pressure on U.S. same-store clinical visits and International same-store sales levels in Q4 reflecting ongoing clinic capacity management dynamics and macro-economic impacts on demand.